Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Lee

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
ACS Applied Materials & Interfaces|June 26, 2018
Low Thermal Boundary Resistance Interfaces for GaN-on-Diamond DevicesLuke Yates, Jonathan Anderson, Xing Gu, et al.
AIP Conference Proceedings|September 28, 2010
Hard X-ray Full Field Nano-imaging of Bone and Nanowires at SSRLJoy C Andrews, Piero Pianetta, Florian Meirer, et al.
Breast Cancer Research : BCR|September 20, 2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumoursJill E Kucab, Cathy Lee, Ching-Shih Chen, et al.
Neurobiology of Aging|April 17, 2012
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging InitiativeJoshua D Grill, Lijie Di, Po H Lu, et al.
Cancer Research|November 1, 2008
Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in miceCathy Lee, Jaspreet Dhillon, Michelle Y C Wang, et al.
Molecular Cancer Therapeutics|November 6, 2009
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomasKaiji Hu, Cathy Lee, Dexin Qiu, et al.
Oncotarget|October 11, 2012
Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomideJoanna Triscott, Cathy Lee, Kaiji Hu, et al.
Nature Communications|October 26, 2021
Pparg signaling controls bladder cancer subtype and immune exclusionTiffany Tate, Tina Xiang, Sarah E Wobker, et al.
Cancer Research|May 3, 2006
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2Joyce Wu, Cathy Lee, Daniel Yokom, et al.
Cureus|February 22, 2024
Effectiveness and Safety of Left Distal Transradial Access in Coronary Procedures in the CaribbeanNaveen A Seecheran, Abel Y Leyva Quert, Valmiki K Seecheran, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
ACS Applied Materials & Interfaces|June 26, 2018
Low Thermal Boundary Resistance Interfaces for GaN-on-Diamond DevicesLuke Yates, Jonathan Anderson, Xing Gu, et al.
AIP Conference Proceedings|September 28, 2010
Hard X-ray Full Field Nano-imaging of Bone and Nanowires at SSRLJoy C Andrews, Piero Pianetta, Florian Meirer, et al.
Breast Cancer Research : BCR|September 20, 2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumoursJill E Kucab, Cathy Lee, Ching-Shih Chen, et al.
Neurobiology of Aging|April 17, 2012
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging InitiativeJoshua D Grill, Lijie Di, Po H Lu, et al.
Cancer Research|November 1, 2008
Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in miceCathy Lee, Jaspreet Dhillon, Michelle Y C Wang, et al.
Molecular Cancer Therapeutics|November 6, 2009
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomasKaiji Hu, Cathy Lee, Dexin Qiu, et al.
Oncotarget|October 11, 2012
Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomideJoanna Triscott, Cathy Lee, Kaiji Hu, et al.
Nature Communications|October 26, 2021
Pparg signaling controls bladder cancer subtype and immune exclusionTiffany Tate, Tina Xiang, Sarah E Wobker, et al.
Cancer Research|May 3, 2006
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2Joyce Wu, Cathy Lee, Daniel Yokom, et al.
Cureus|February 22, 2024
Effectiveness and Safety of Left Distal Transradial Access in Coronary Procedures in the CaribbeanNaveen A Seecheran, Abel Y Leyva Quert, Valmiki K Seecheran, et al.
Pageof 8